What are the typical presentations of a patient with nephrolithiasis (kidney stones)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Patients with kidney stones typically present with sudden, severe flank pain that may radiate to the groin, often described as colicky in nature, and the most effective management strategy to prevent recurrent nephrolithiasis is to increase fluid intake to achieve at least 2 L of urine per day, as recommended by the American College of Physicians 1.

Key Symptoms and Diagnosis

The symptoms associated with kidney stones include:

  • Nausea
  • Vomiting
  • Hematuria (blood in urine)
  • Dysuria (painful urination)
  • Urinary frequency
  • Urgency Some patients may develop fever and chills if infection is present, which constitutes a medical emergency. Physical examination may reveal costovertebral angle tenderness on the affected side. Diagnosis involves urinalysis (showing hematuria), imaging (typically non-contrast CT scan, which is most sensitive for detecting stones), and blood tests to assess kidney function and identify any metabolic abnormalities.

Management and Prevention

Initial management includes pain control with NSAIDs like ketorolac (30mg IV or 10mg orally every 6 hours) or opioids if needed, adequate hydration, and antiemetics for nausea. Medical expulsive therapy with tamsulosin 0.4mg daily may help pass stones <10mm. Stones larger than 10mm, those causing complete obstruction, or cases complicated by infection typically require urological intervention such as extracorporeal shock wave lithotripsy, ureteroscopy, or percutaneous nephrolithotomy. Prevention strategies include increased fluid intake (2-3 liters daily), dietary modifications based on stone composition, and sometimes medications like thiazide diuretics, allopurinol, or potassium citrate depending on the underlying metabolic abnormality, as supported by recent guidelines 1.

Recent Guidelines and Recommendations

The American College of Physicians recommends management with increased fluid intake spread throughout the day to achieve at least 2 L of urine per day to prevent recurrent nephrolithiasis 1. Additionally, pharmacologic monotherapy with a thiazide diuretic, citrate, or allopurinol may be recommended to prevent recurrent nephrolithiasis in patients with active disease in which increased fluid intake fails to reduce the formation of stones 1. The most recent guidelines from the Journal of the American College of Radiology also emphasize the importance of imaging in the diagnosis and management of kidney stones, particularly in assessing alternative diagnoses, complications, and appropriateness of potential therapies 1.

From the Research

Patient Presentation

Kidney stone patients often present with various symptoms, including severe pain, nausea, and vomiting. The evaluation of these patients is crucial in identifying the underlying causes of stone formation and guiding treatment.

Evaluation Process

The evaluation process for kidney stone patients typically involves:

  • Radiologic studies to identify the stone burden and monitor treatment success 2
  • Laboratory evaluations to identify systemic disorders, such as 24-hour urine chemistries for patients with multiple kidney stones 2
  • Identification of dietary, environmental, and genetic factors that contribute to stone risk 2

Medical Management

Medical management of kidney stones may involve the use of alpha-blockers, such as tamsulosin, to enhance stone clearance and reduce symptoms:

  • Alpha-blockers have been shown to improve stone clearance rates and reduce the need for auxiliary treatments 3
  • Tamsulosin has been found to be effective in enhancing the passage of renal and ureteral stones, particularly those 10-24 millimeters in diameter 4
  • Alpha-blockers may also reduce major adverse events and stone clearance time 3

Treatment Considerations

Treatment considerations for kidney stone patients may include:

  • The use of alpha-blockers without lithotripsy for ureteral stones ≤10 mm 5
  • The use of alpha-blockers post-lithotripsy for renal or ureteral stones >10 mm 5
  • The identification of underlying causes of stone formation, such as genetic or environmental factors, to guide prevention and treatment 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation of the kidney stone patient.

Seminars in nephrology, 2008

Research

Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults.

The Cochrane database of systematic reviews, 2020

Research

Efficacy and Safety of Alpha-Blockers for Kidney Stones in Adults.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 2018

Research

Kidney stones: pathophysiology and medical management.

Lancet (London, England), 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.